Adelaide Research & Scholarship: Search

Search

Results 1-9 of 9 (Search time: 0.002 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2006	Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA	Crawley, A.; Gliddon, B.; Auclair, D.; Brodie, S.; Hirte, C.; King, B.; Fuller, M.; Hemsley, K.; Hopwood, J.
	2007	Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice	Hemsley, K.; King, B.; Hopwood, J.
	2009	Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs-A proof of principle study	Hemsley, K.; Norman, E.; Crawley, A.; Auclair, D.; King, B.; Fuller, M.; Lang, D.; Dean, C.; Jolly, R.; Hopwood, J.
	2006	Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA	King, B.; Savas, P.; Fuller, M.; Hopwood, J.; Hemsley, K.
	2011	Enzyme replacement reduces neuropathology in MPS IIIA dogs	Crawley, A.; Marshall, N.; Beard, H.; Hassiotis, S.; Walsh, V.; King, B.; Hucker, N.; Fuller, M.; Jolly, R.; Hopwood, J.; Hemsley, K.
	2009	Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease	Hemsley, K.; Luck, A.; Crawley, A.; Hassiotis, S.; Beard, H.; King, B.; Rozek, T.; Rozaklis, T.; Fuller, M.; Hopwood, J.
	2008	Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice	Hemsley, K.; Beard, H.; King, B.; Hopwood, J.
	2014	Disease stage determines the efficacy of treatment of a paediatric neurodegenerative disease	Hassiotis, S.; Beard, H.; Luck, A.; Trim, P.; King, B.; Snel, M.; Hopwood, J.; Hemsley, K.
	2013	Neonatal bone marrow transplantation in MPS IIIA mice	Lau, A.; Shamsani, N.; Winner, L.; Hassiotis, S.; King, B.; Hopwood, J.; Hemsley, K.